APA   Click to copy
S, M., R, Z., J, D. L., JV, R., C, C., S, W., … RT, N. (2023). Baseline Relationships Between Measures of Cognitive Function and Patient-Reported Outcomes in Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Phase 3b Study of Ozanimod. San Diego, CA.

Chicago/Turabian   Click to copy
S, Morrow, Zivadinov R, DeLuca J, Riolo JV, Cheng C, Wray S, Bass A, et al. “Baseline Relationships Between Measures of Cognitive Function and Patient-Reported Outcomes in Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Phase 3b Study of Ozanimod.” Americas Committee for Treatment and Research in Multiple Sclerosis Forum. San Diego, CA, 2023.

MLA   Click to copy
S, Morrow, et al. Baseline Relationships Between Measures of Cognitive Function and Patient-Reported Outcomes in Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Phase 3b Study of Ozanimod. 2023.

@inproceedings{morrow2023a,
  title = {Baseline Relationships Between Measures of Cognitive Function and Patient-Reported Outcomes in Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Phase 3b Study of Ozanimod.},
  year = {2023},
  address = {San Diego, CA},
  series = {Americas Committee for Treatment and Research in Multiple Sclerosis Forum},
  author = {S, Morrow and R, Zivadinov and J, DeLuca and JV, Riolo and C, Cheng and S, Wray and A, Bass and E, Fox and E, Riser and B, Chaudhry and J, Reardon and D, Silva and RT, Naismith}
}